Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis
This study looks at using special medicated eye drops to treat eye problems in people with cystinosis, a rare condition where crystals build up in the body. By dissolving these crystals in the cornea, the drops help reduce eye pain and keep the surface of the eye healthy.
This trial is open to patients aged 2 and older who have a confirmed diagnosis of cystinosis. Participants must be willing and able to travel to the study site for regular check-ups and complete specific eye exams.
Participants use cysteamine eye drops regularly to help clear crystals from their eyes. They will also visit the clinic for check-ups and special microscope exams to make sure their eyes are healthy and the treatment is working.
The study takes place in Bethesda, Maryland, at the NIH. This trial has reached its goals and is now completed.
- 1The eye drops are very effective, but they only work if you use them exactly as prescribed.
- 2This treatment focuses on clearing crystals from the eye to prevent pain and surface damage.
- 3Participation requires the ability to travel to the clinic for periodic monitoring and detailed eye exams.
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.